Private Advisor Group, LLC Durect Corp Transaction History

Private Advisor Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$0.38 - $0.64 $3,150 - $5,305	-8,290 Reduced 40.99%	11,935 $6,000
Q1 2022 May 12, 2022	SELL	$0.55 - $0.98 $3,510 - $6,255	-6,383 Reduced 23.99%	20,225 $14,000
Q4 2021 Feb 10, 2022	SELL	$0.9 - $1.31 $5,452 - $7,935	-6,058 Reduced 18.55%	26,608 $26,000
Q3 2021 Oct 14, 2021	BUY	$1.21 - $1.61 $13,127 - $17,466	10,849 Added 49.73%	32,666 $43,000
Q2 2021 Aug 12, 2021	BUY	$1.6 - $2.02 $99 - $125	62 Added 0.28%	21,817 $35,000
Q1 2021 Apr 22, 2021	BUY	$1.86 - $2.87 $2,111 - $3,257	1,135 Added 5.5%	21,755 $43,000
Q4 2020 Apr 01, 2021	SELL	$1.65 - $2.43 $3,927 - $5,783	-2,380 Reduced 10.35%	20,620 $43,000
Q1 2020 May 12, 2020	BUY	$0.97 - $2.85 $22,310 - $65,550	23,000 New	23,000 $36,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $173M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.